---
title: "ACXP.US (ACXP.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ACXP.US/news.md"
symbol: "ACXP.US"
name: "ACXP.US"
parent: "https://longbridge.com/en/quote/ACXP.US.md"
datetime: "2026-06-13T22:01:23.777Z"
locales:
  - [en](https://longbridge.com/en/quote/ACXP.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ACXP.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ACXP.US/news.md)
---

# ACXP.US (ACXP.US) — Related News

### [07:01 ETAcurx Pharmaceuticals, Inc. Reports First Quarter 2026 results and Provides Business Update](https://longbridge.com/en/news/286085112.md)
*2026-05-12T11:02:18.000Z*
> Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) reported its first quarter 2026 results, highlighting significant development

### [Acurx Pharmaceuticals | 10-Q: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/285988887.md)
*2026-05-11T20:09:12.000Z*
### [ACXP Q1'26 Earnings: EPS estimate is (1.20) USD](https://longbridge.com/en/news/285928591.md)
*2026-05-11T11:00:32.000Z*
> ACXP (Acurx Pharmaceuticals, Inc.) is set to announce its Q1'26 results on May 12, after the market closes. The earnings

### [Acura Pharmaceuticals Secures Insider Loans Amid Liquidity Strain](https://longbridge.com/en/news/285566584.md)
*2026-05-07T13:54:15.000Z*
> Acura Pharmaceuticals has secured four additional $100,000 loans from major shareholder Abuse Deterrent Pharma, LLC, inc

### [Acurx Pharmaceuticals, Inc. Announces Closing of up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | ACXP Stock News](https://longbridge.com/en/news/283047832.md)
*2026-04-16T12:01:00.000Z*
> Acurx Pharmaceuticals, Inc. has closed a registered direct offering of 825,085 shares at $3.03 per share, raising approx

### [](https://longbridge.com/en/news/283032107.md)
*2026-04-16T15:59:56.000Z*
> Acurx Pharmaceuticals shares are trading lower after the company announced a $7.1 million registered direct offering.